NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, announced that BioClinica WebSend has been included in more than 90% of its 2011 imaging core lab business signings. WebSend benefits clinical trials by speeding access to clinical imaging data while reducing errors and costs by securely sending medical images over the Internet, rather than using courier services.
